69 related articles for article (PubMed ID: 3506525)
21. Stimulation of UV-induced DNA excision repair by chemotherapeutic drugs in cancer patients.
Roth M; Rogers S; Roberts SS; Boyle JM; Müller HJ; Weber W
Anticancer Res; 1994; 14(3A):809-15. PubMed ID: 8074483
[TBL] [Abstract][Full Text] [Related]
22. Variations in the content of CD34+ cells in the peripheral blood of cancer patients receiving out-patient chemotherapy.
Waller EK; Barlett N; Chen CH; Mujic V; Sussman H; Toepker S; Grenier K
Cytotherapy; 1999; 1(1):21-9. PubMed ID: 19746646
[TBL] [Abstract][Full Text] [Related]
23. High mutagen sensitivity in peripheral blood lymphocytes predicts poor overall and disease-specific survival in patients with stage III non-small cell lung cancer treated with radiotherapy and chemotherapy.
Chang JY; Komaki R; Sasaki R; Liao Z; Stevens CW; Lu C; Fossella FV; Allen PK; Cox JD; Spitz MR; Wu X
Clin Cancer Res; 2005 Apr; 11(8):2894-8. PubMed ID: 15837739
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients.
Tampellini M; Berruti A; Bitossi R; Gorzegno G; Alabiso I; Bottini A; Farris A; Donadio M; Sarobba MG; Manzin E; Durando A; Defabiani E; De Matteis A; Ardine M; Castiglione F; Danese S; Bertone E; Alabiso O; Massobrio M; Dogliotti L
Breast Cancer Res Treat; 2006 Aug; 98(3):241-8. PubMed ID: 16670941
[TBL] [Abstract][Full Text] [Related]
25. Occurrence of monocytoid B lymphocytes in lymph nodes of patients treated by chemotherapy.
Ohnishi A; Ohsawa M; Yasunaga Y; Ijuin N; Sawada M; Yamamoto S; Aozasa K
J Surg Oncol; 1996 Aug; 62(4):245-8. PubMed ID: 8691836
[TBL] [Abstract][Full Text] [Related]
26. Long-term effects of postoperative adjuvant chemotherapy on the immune system in 100 cancer patients.
Israel L; Samak R; Grefft-Alami A; Edelstein R
Prog Clin Biol Res; 1983; 132E():35-44. PubMed ID: 6647476
[No Abstract] [Full Text] [Related]
27. Remission induction chemotherapy induces in vivo caspase-dependent apoptosis in bone marrow acute myeloid leukemia blast cells and spares lymphocytes.
Vial JP; Tabrizi R; Pigneux A; Lacombe F; Praloran V; Belloc F
Cytometry B Clin Cytom; 2006 May; 70(3):115-23. PubMed ID: 16572429
[TBL] [Abstract][Full Text] [Related]
28. Pattern of adverse drug reactions due to cancer chemotherapy in a tertiary care teaching hospital in Nepal.
Mallik S; Palaian S; Ojha P; Mishra P
Pak J Pharm Sci; 2007 Jul; 20(3):214-8. PubMed ID: 17545106
[TBL] [Abstract][Full Text] [Related]
29. The pattern of fetal hemoglobin changes in patients with malignancy on chemotherapy.
Abdel-Razeq HN; Zaru L
Saudi Med J; 2007 Apr; 28(4):658; author reply 658. PubMed ID: 17457506
[No Abstract] [Full Text] [Related]
30. Therapy control in oncology by circulating nucleosomes.
Holdenrieder S; Stieber P
Ann N Y Acad Sci; 2004 Jun; 1022():211-6. PubMed ID: 15251962
[TBL] [Abstract][Full Text] [Related]
31. An imaging-based rapid evaluation method for complement-dependent cytotoxicity discriminated clinical response to rituximab-containing chemotherapy.
Mishima Y; Sugimura N; Matsumoto-Mishima Y; Terui Y; Takeuchi K; Asai S; Ennishi D; Asai H; Yokoyama M; Kojima K; Hatake K
Clin Cancer Res; 2009 May; 15(10):3624-32. PubMed ID: 19417028
[TBL] [Abstract][Full Text] [Related]
32. Human natural killer cells: a comprehensive review.
Sinkovics JG; Horvath JC
Int J Oncol; 2005 Jul; 27(1):5-47. PubMed ID: 15942642
[TBL] [Abstract][Full Text] [Related]
33. The dynamics of morphological and cytoenzymatic changes in peripheral blood lymphocyte lysosomes in patients with chronic lymphocytic leukemia during treatment.
Grabarczyk M; Sitarska E; Leszko B
Arch Immunol Ther Exp (Warsz); 1983; 31(4):475-80. PubMed ID: 6670917
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of the efficacy of chemotherapy with oxaliplatin plus 5-fluorouracil by pretreatment with IL-2 subcutaneous immunotherapy in metastatic colorectal cancer patients with lymphocytopenia prior to therapy.
Lissoni P; Brivio F; Fumagalli L; Di Fede G; Brera G
In Vivo; 2005; 19(6):1077-80. PubMed ID: 16277025
[TBL] [Abstract][Full Text] [Related]
35. The drug-immune system interaction in cancer therapy.
Ghione M
Int J Tissue React; 1984; 6(6):513-21. PubMed ID: 6530355
[TBL] [Abstract][Full Text] [Related]
36. [Polychemotherapy-induced changes in the antioxidant state of blood in patients with inoperable cancer of the stomach].
Frantsiiants EM; Orlovskaia LA; Shalashnaia EV; Mucienko NV; Anapalian BKh
Vopr Onkol; 1999; 45(6):607-11. PubMed ID: 10703506
[TBL] [Abstract][Full Text] [Related]
37. Nutritional status of cancer patients given different treatment modalities.
Usharani K; Roy RK; Vijayalakshmi ; Prakash J
Int J Food Sci Nutr; 2004 Aug; 55(5):363-9. PubMed ID: 15545044
[TBL] [Abstract][Full Text] [Related]
38. Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial.
Pierga JY; Bidard FC; Mathiot C; Brain E; Delaloge S; Giachetti S; de Cremoux P; Salmon R; Vincent-Salomon A; Marty M
Clin Cancer Res; 2008 Nov; 14(21):7004-10. PubMed ID: 18980996
[TBL] [Abstract][Full Text] [Related]
39. The pattern of fetal hemoglobin changes in patients with malignancy on chemotherapy.
Omoti CE; Osime EO; Omuemu CE
Saudi Med J; 2006 Oct; 27(10):1523-5. PubMed ID: 17013475
[TBL] [Abstract][Full Text] [Related]
40. Cellular effects of cancer chemotherapy administration.
Moran P
J Intraven Nurs; 2000; 23(1):44-51. PubMed ID: 11013533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
